论文信息 - Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial - 字舞流文

Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial

R. Elashoff | F. Martinez | M. Roth | M. Mayes | J. Golden | J. Goldin | C. Strange | C. Read | D. Furst | C. Tseng | M. Scholand | R. Simms | J. Varga | M. Fritzler | D. Khanna | R. Wise | V. Steen | A. Fischer | P. Clements | V. Hsu | R. Silver | B. Patel | A. Theodore | D. Tashkin | S. Hussain | M. Hinchcliff | K. Phillips | J. Molitor | T. Frech | F. Wigley | S. Kafaja | S. Assassi | J. Swigris | G. Kim | E. Kleerup | K. Highland | D. Schraufnagel | E. Volkmann | D. J. Riley | Michael D. Roth | S. Volkov | R. Meehan | M. K. Connolly | K. Connolly | E. Arriola | J. Dematte | J. Golden | D. Riley | Jeff rey Swigris | David J. Riley | Dean E. Schraufnagel | D. P. Tashkin | Philip J. Clements | D. Tashkin | Charles A Read | Daniel E. Furst | Jeff rey Golden | Kari Connolly | J. Swigris | Marvin J. Fritzler | G. H. J. Kim | Daniel E Furst